Drugs / JYB1907
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05821595 | Jul 2023 → Sep 2024 | cancer | Jemincare | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JYB1907 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05821595 ↗ |
| Action | Inhibit | “TGF-β inhibitor” NCT05821595 ↗ |
| Route | Intravenous | “intravenous administration” NCT05821595 ↗ |